Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$597M |
| 2 |
FRC
First Republic Bank
FRC
|
+$395M |
| 3 |
Western Midstream Partners
WES
|
+$368M |
| 4 |
Walt Disney
DIS
|
+$319M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.07B |
| 2 |
Apple
AAPL
|
+$881M |
| 3 |
Alibaba
BABA
|
+$791M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$738M |
| 5 |
Starbucks
SBUX
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.24% |
| 2 | Financials | 9.92% |
| 3 | Healthcare | 9.06% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Energy | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Vitamin Cottage Natural Grocers
NGVC
$739M
| $250K | ﹤0.01% |
20,845
-17,686
| -46% | -$250K |
|
4652
CALL
Broadridge
BR
$17.8B
| $249K | ﹤0.01% |
+2,400
| New | +$241K |
|
|
SIOX
4653
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $249K | ﹤0.01% |
23,398
+17,611
| +304% | +$175K |
|
4654
Goldgroup Mining Inc.
GORO
$157M
| $248K | ﹤0.01% |
63,232
+607
| +1% | +$2.63K |
|
4655
BCB Bancorp
BCBP
$173M
| $247K | ﹤0.01% |
+18,460
| New | +$224K |
|
4656
WisdomTree International Equity Fund
DWM
$679M
| $247K | ﹤0.01% |
4,882
-54,442
| -92% | -$2.71M |
|
4657
Avalo Therapeutics
AVTX
$965M
| $246K | ﹤0.01% |
+15
| New | +$224K |
|
|
NVTR
4658
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $246K | ﹤0.01% |
+22,318
| New | +$301K |
|
|
BLDP
4659
Ballard Power Systems
BLDP
$805M
| $245K | ﹤0.01% |
81,116
+6,176
| +8% | +$20.2K |
|
4660
Grupo Aval
AVAL
$6.27B
| $244K | ﹤0.01% |
31,278
-356
| -1% | -$2.56K |
|
|
LAND
4661
Gladstone Land Corp
LAND
$350M
| $244K | ﹤0.01% |
19,257
-10,605
| -36% | -$128K |
|
|
STKL
4662
PUT
DELISTED
SunOpta
STKL
| $244K | ﹤0.01% |
70,400
-40,000
| -36% | -$155K |
|
|
ADAP
4663
DELISTED
Adaptimmune Therapeutics
ADAP
| $243K | ﹤0.01% |
56,582
+21,201
| +60% | +$98.7K |
|
|
OPTN
4664
DELISTED
OptiNose
OPTN
| $243K | ﹤0.01% |
1,575
-361
| -19% | -$41.9K |
|
|
ASXC
4665
DELISTED
Asensus Surgical, Inc.
ASXC
| $242K | ﹤0.01% |
7,829
-13,363
| -63% | -$448K |
|
4666
Civeo
CVEO
$345M
| $241K | ﹤0.01% |
9,585
+5,080
| +113% | +$138K |
|
|
RYZ
4667
Ryerson Holding Corp
RYZ
$1.44B
| $241K | ﹤0.01% |
28,117
+636
| +2% | +$4.93K |
|
4668
Sonida Senior Living
SNDA
$1.91B
| $241K | ﹤0.01% |
4,026
+3,126
| +347% | +$283K |
|
|
XONE
4669
DELISTED
The ExOne Company
XONE
| $240K | ﹤0.01% |
28,263
+17,950
| +174% | +$166K |
|
|
LGCY
4670
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
| $240K | ﹤0.01% |
+488,583
| New | +$659K |
|
4671
Coca-Cola Femsa
KOF
$22.7B
| $239K | ﹤0.01% |
3,618
-11,168
| -76% | -$700K |
|
4672
State Street SPDR S&P China ETF
GXC
$462M
| $238K | ﹤0.01% |
2,370
-945
| -29% | -$89.8K |
|
|
MTEM
4673
DELISTED
Molecular Templates, Inc.
MTEM
| $238K | ﹤0.01% |
2,734
+249
| +10% | +$18.3K |
|
|
ODT
4674
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $238K | ﹤0.01% |
+10,771
| New | +$188K |
|
4675
First Northwest Bancorp
FNWB
$109M
| $237K | ﹤0.01% |
15,226
+3,120
| +26% | +$48.8K |
|
Similar funds
Goldman Sachs's Q1 2019 Portfolio in Review
As of Q1 2019, Goldman Sachs held 5,713 positions worth $331B, up 5.5% from $314B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Goldman Sachs withdrew a net $23.8B in Q1 2019, closing 640 positions and reducing 2,111 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $467M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Fox Class B worth $104M.
- Goldman Sachs's largest Q1 2019 buy was Fox Class B: 2,897,722 shares worth $104M.
- Goldman Sachs added most to Pfizer in Q1 2019, an estimated $597M increase.
- Goldman Sachs's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.07B.
- Goldman Sachs fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $467M.
- Goldman Sachs's ten largest holdings make up 13% of its $331B portfolio in Q1 2019.
- Goldman Sachs opened 529 new positions and closed 640 in Q1 2019.
- Goldman Sachs's portfolio value rose 5.5% quarter-over-quarter to $331B.
Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.